GEST 2021 Accrediation
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must attend the entire webinar as partial credit is not available. lf you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
||ln support of improving patient care, this activity has been planned and implemented by Amedco LLC and Global Embolization Symposium and Technologies. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Category A+ continuing education units are offered as approved by the Association of Vascular and Interventional Radiographers. The GEST 2021 Annual Meeting program offers up to 16.5 CEU credits.
Objectives - After Attending This Program You Should Be Able To
- Discuss the latest therapeutic embolization options, assess standard and/or advanced imaging techniques in various embolotherapy applications such as: interventional oncology, lymphatic interventions, musculoskeletal (MSK) applications, trauma, bariatric, hemorrhoid-related bleeding, pelvic congestion syndrome (PCS), varicocele, visceral aneurysms, endoleak, portal interventions, renal interventions, vascular malformations, trauma, critical care, women’s health, and men’s health
- Understand anatomy, indications, contraindications, patient planning, and potential complications for embolization and interventional procedures
- Understand different embolization treatment options by function, characteristics, latest evidence and potential outcomes in various embolotherapy applications
Disclosure of Conflict of lnterest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed in the program book. lf their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.
Each Focus Day Has Its Own Accreditation Information Which Can Be Viewed Here: